Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

122 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)

NCT03833180

Conditions
Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +49 more
Locations
  • City of Hope ( Site 0010) Duarte, California, United States
  • University of California - San Diego ( Site 0003) La Jolla, California, United States
  • UCLA Hematology & Oncology ( Site 0007) Los Angeles, California, United States
  • University of Nebraska Medical Center ( Site 0006) Omaha, Nebraska, United States
View all 14 locations
View Trial Details
Completed

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

NCT00406809

Conditions
Chronic Lymphoid Leukemia, Follicular Lymphoma, Hematologic Diseases, +25 more
Locations
  • Site Reference ID/Investigator# 4997 Los Angeles, California, United States
  • Site Reference ID/Investigator# 9104 Los Angeles, California, United States
  • Site Reference ID/Investigator# 2613 Bethesda, Maryland, United States
  • Site Reference ID/Investigator# 40243 Boston, Massachusetts, United States
View Trial Details
Completed

BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia

NCT02933320

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • Leicester Royal Infirmary Leicester, England, United Kingdom
  • Christie Hospital Manchester, England, United Kingdom
  • Oxford Cancer and Haematology Centre, Churchill Hospital Oxford, England, United Kingdom
  • Derriford Hospital Plymouth, United Kingdom
View Trial Details
Completed

Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL

NCT01659255

Conditions
Chronic Lymphocytic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • CHRU - Hopital Claude HURIEZ Lille, France
  • Centre hospitalier Lyon Sud Lyon, France
  • CHU St Eloi Montpellier, France
  • University Hospital of Wales Cardiff, United Kingdom
View Trial Details

Related conditions